Canaccord Genuity Maintains Buy on Artivion, Raises Price Target to $40
Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $39 to $40.
Read original at benzingaStocks · News reference
Needham Reiterates Buy on Artivion, Maintains $44 Price Target
Needham analyst Mike Matson reiterates Artivion (NYSE:AORT) with a Buy and maintains $44 price target.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 20, 2026, 10:12 AM
- Checked
- Jul 20, 2026, 10:12 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Artivion Affirms FY2026 Sales Guidance of $480.000M-$496.000M vs $486.232M Est
Artivion (NYSE:AORT) affirms FY2026 sales outlook from $480.000 million-$496.000 million to $480.000 million-$496.000 million vs $486.232 million estimate.
Read original at benzingaArtivion Q2 Adj. EPS $0.13 Beats $0.01 Estimate, Sales $125.757M Beat $120.012M Estimate
Read original at benzinga